 treatment anemia chronic renal failur subcutan recombin human erythropoietin purpos purpos studi efficaci recombin human erythropoietin rhuepo times/week patient chronic renal failur anemia predialysi patient method eleven patient predialysi chronic renal failur double-blind placebo-control studi erythropoietin week patient rhuepo mu/kg bodi times/week placebo week placebo patient rhuepo dose mu/kg times/week target hematocrit studi blood pressur blood work hemoglobin hematocrit reticulocyt count iron profil determin result week hematocrit treat group placebo group baselin hematocrit week week rhuepo therapi hematocrit prior placebo group versu baselin signific chang biochem paramet mean blood pressur valu compar treatment iron supplement patient rate progress renal failur hematocrit rhuepo conclus rhuepo effect safe therapi patient chronic renal failur anem dialysi